Galli, Elena
 Distribuzione geografica
Continente #
NA - Nord America 3.457
AS - Asia 2.282
EU - Europa 1.447
SA - Sud America 381
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 44
OC - Oceania 17
Totale 7.687
Nazione #
US - Stati Uniti d'America 3.347
SG - Singapore 717
CN - Cina 610
IT - Italia 600
BR - Brasile 290
HK - Hong Kong 277
VN - Vietnam 263
GB - Regno Unito 172
BD - Bangladesh 123
SE - Svezia 123
FI - Finlandia 104
RU - Federazione Russa 97
DE - Germania 87
KR - Corea 84
FR - Francia 74
CA - Canada 47
NL - Olanda 43
ID - Indonesia 40
AR - Argentina 37
JP - Giappone 28
AT - Austria 27
MX - Messico 27
IN - India 23
TR - Turchia 21
IQ - Iraq 20
BG - Bulgaria 19
PL - Polonia 18
AU - Australia 17
MA - Marocco 17
EC - Ecuador 14
LT - Lituania 13
PK - Pakistan 12
CL - Cile 11
ES - Italia 11
AE - Emirati Arabi Uniti 10
CO - Colombia 9
CR - Costa Rica 9
IE - Irlanda 9
ZA - Sudafrica 9
PT - Portogallo 8
JM - Giamaica 7
TW - Taiwan 7
VE - Venezuela 7
EG - Egitto 6
HU - Ungheria 6
KG - Kirghizistan 6
PE - Perù 6
UA - Ucraina 6
IL - Israele 5
KE - Kenya 5
MY - Malesia 5
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
GR - Grecia 4
GT - Guatemala 4
BE - Belgio 3
IR - Iran 3
PH - Filippine 3
PY - Paraguay 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
AG - Antigua e Barbuda 2
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GY - Guiana 2
JO - Giordania 2
NI - Nicaragua 2
RS - Serbia 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CU - Cuba 1
DK - Danimarca 1
EU - Europa 1
GD - Grenada 1
GP - Guadalupe 1
IM - Isola di Man 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
OM - Oman 1
PA - Panama 1
Totale 7.622
Città #
Santa Clara 502
Ashburn 463
Singapore 417
Hong Kong 274
San Jose 268
Hefei 238
Council Bluffs 162
Chandler 150
Fairfield 145
Ho Chi Minh City 98
London 94
Helsinki 92
Beijing 88
Nyköping 82
Seoul 82
New York 77
Los Angeles 71
Milan 70
Dallas 50
The Dalles 50
Moscow 49
Hanoi 46
Seattle 46
Wilmington 45
Chicago 44
Cambridge 41
Bologna 40
Houston 38
Woodbridge 37
Buffalo 36
Rome 32
Shanghai 28
Jakarta 27
Lauterbourg 26
São Paulo 24
Modena 23
Munich 23
Princeton 23
San Diego 22
Salt Lake City 21
Nuremberg 19
Tokyo 18
Atlanta 17
Florence 17
Sofia 17
Ann Arbor 16
Brooklyn 15
Kent 15
Naples 15
Da Nang 14
Southend 14
Columbus 13
Haiphong 13
Orem 13
Rio de Janeiro 13
Boardman 12
Louisville 12
Parma 12
Redondo Beach 12
Reggio Emilia 12
Ankara 10
Mexico City 10
North Bergen 10
Portsmouth 10
Vienna 10
Biên Hòa 9
Brasília 9
Denver 9
Elk Grove Village 9
Frankfurt am Main 9
Melbourne 9
Phoenix 9
Saint Augustine 9
Toronto 9
Bremen 8
Casablanca 8
Des Moines 8
Dublin 8
Ksawerów 8
Lappeenranta 8
Philadelphia 8
Porto Alegre 8
Warsaw 8
Amsterdam 7
Bari 7
Dearborn 7
Dhaka 7
Montreal 7
Padova 7
Tampa 7
Washington 7
Cagliari 6
Chennai 6
Lahore 6
Miano 6
Palermo 6
Paris 6
Quito 6
Reston 6
San José 6
Totale 4.746
Nome #
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 373
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis 360
Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT 308
EULAR guidelines on ANCA-associated vasculitis in the real life 295
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 269
Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy for Giant Cell Arteritis 261
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 250
AB0611 STRAIN ANALYSIS OF THE RIGHT VENTRICLE USING 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS 245
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 236
Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study 230
Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study 216
Reggio Emilia (Northern Italy) Interdisciplinary Uveitis Clinic: What We Have Learned in the Last 20 Years 214
Vessel inflammation and morphological changes in patients with large vessel vasculitis: A retrospective study 212
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 200
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: Multicenter retrospective study of 209 patients 198
Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: A matched cross-sectional study 191
Significance of inflammation restricted to adventitial/periadventitial tissue on temporal artery biopsy 191
THU0600 a case of systemic sclerosis complicated by renal crisis: potential etiopathogenetic role of cytomegalovirus and treatment 188
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study 187
Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases 186
Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways 182
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 178
Failure of first anti-TNF agent in Takayasu's arteritis: to switch or to swap? 177
Development of the Takayasu Arteritis Integrated Disease Activity Index 175
What to Know About Biopsy Sampling and Pathology in Vasculitis? 175
Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study 164
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study 160
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 156
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 156
C-reactive protein gene polymorphisms influence susceptibility and outcomes of biopsy-proven giant cell arteritis in Italian patients 155
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 152
The management of large vessel vasculitides 152
Pros and cons of TNF inhibitors and tocilizumab in the treatment of large-vessel vasculitis 140
Current management of giant cell arteritis and its complications 137
Response to ‘The Relevance of Restricted Inflammation in a TAB’ by Griffin KJ et al 134
The Role of PET in the Diagnosis and Disease Activity Assessment in Large Vessel Vasculitis 133
Reply 131
Response to: COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: A cross-sectional patient survey study' by Cuceoglu et al 128
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 92
Totale 7.687
Categoria #
all - tutte 33.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022339 0 0 0 18 14 26 23 24 38 28 98 70
2022/2023590 54 64 33 35 71 76 31 66 82 17 32 29
2023/2024493 12 30 14 58 47 49 59 78 20 33 42 51
2024/20251.740 33 20 23 119 350 293 162 62 177 113 192 196
2025/20263.324 264 188 295 401 357 203 388 172 371 238 251 196
2026/2027849 123 180 205 341 0 0 0 0 0 0 0 0
Totale 7.687